-
The left atrial appendage is thought to be the source of a large proportion of emboli in patients with nonvalvular atrial fibrillation. In this paper, Bartus and his colleagues describe an innovative new device that uses a combined transseptal-epicardial approach to ligate the left atrial appendage.
-
Menopausal hormone therapy and risk of VTE and AD; patients' understanding of chemotherapy benefits; and FDA actions.
-
-
-
This paper reviews the recent data on the effectiveness of cardiac resynchronization therapy (CRT) in patients with milder forms of heart failure (NYHA classes 1 and 2) and revises the Heart Failure Society of America's (HFSA) 2010 Guidelines.
-
This report from a consortium of Canadian implantable cardioverter-defibrillator (ICD) implantation centers analyzed predictors of failure of the Medtronic Sprint Fidelis lead.
-
For those who perform percutaneous coronary intervention (PCI), the newer generation stents have obvious benefits during the procedure.
-
Statins and diabetes risk; new treatment guideline for diabetes; new pertussis vaccine recommendation; antibiotics and rhinosinusitis; fluoroquinolones and cystitis; and FDA actions.
-
The value of high sensitivity C-reactive protein (CRP) measurements in the management of patients at risk for cardiovascular (CV) events is controversial.
-
Although a routine part of a complete medical history, the value of systematically collecting family history has not been shown in controlled trials.
